Strides Pharma Science Limited (Strides) maanta waxay ku dhawaaqday inay hoos u dhigtay kaabadeeda oo dhan, Strides Pharma Global Pte. Limited, Singapore, ayaa ogolaansho ka heshay kaabsoosha Tetracycline Hydrochloride USP, 250 mg iyo 500 mg Maamulka Cuntada & Dawooyinka ee Maraykanka (USFDA). Alaabtu waa nooc guud oo ah Achromycin V Capsules, 250 mg iyo 500 mg, ee Avet Pharmaceuticals Inc (hore Heritage Pharmaceuticals Inc.) Marka loo eego xogta IQVIA MAT, suuqa Maraykanka ee Tetracycline Hydrochloride Capsules USP, 250 mg iyo 500 mg waa qiyaastii 500 mg. US$ 16 Mn. Badeecada waxaa lagu soo saari doonaa xarunta caanka ah ee shirkadda ee Bangalore waxaana suuqgeyn doona Strides Pharma Inc. ee suuqyada Maraykanka.Shirkaddu waxay haysataa 123 faylood oo ANDA ah oo ay la socdaan USFDA kuwaas oo 84 ANDAs la oggolaaday iyo 39 ay sugayaan oggolaansho. Tetracycline Hydrochloride Capsule waa antibiyootiko loo isticmaalo in lagu daweeyo caabuqyada bakteeriyada kala duwan ee maqaarka, xiidmaha, mareenka neefsiga, kaadi mareenka, xubnaha taranka, qanjidhada qanjidhada, iyo hababka kale ee jidhka. Xaaladaha qaarkood, tetracycline Hydrochloride Capsule waxaa loo isticmaalaa marka penicillin ama antibiyootiko kale aan loo isticmaali karin daaweynta caabuqyada halista ah sida Anthrax, Listeria, Clostridium, Actinomyces.Shares of Strides Pharma Science Ltd waxay ahayd ganacsigii ugu dambeeyay ee BSE Rs.466.65 marka loo eego xiritaankii hore ee Rs. 437. Wadarta guud ee saamiyada la kala iibsaday maalintii waxay ahayd 146733 in ka badan 5002 ganacsi. 473.4 iyo maalintii hoose ee 440. Dakhliga saafiga ah ee maalintii wuxuu ahaa Rs. 66754491.